Adage Capital Partners’s Immunomedics Inc IMMU Stock Holding History

Adage Capital Partners’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,200,000	Closed	-$102M	–	910
2020 Q3	$102M	Buy	+1,200,000	New	+$60.7M	0.26%	85
2018 Q4	–	Sell	-290,000	Closed	-$6.04M	–	778
2018 Q3	$6.04M	Buy	290,000 +140,000	+93%	+$3.32M	0.01%	619
2018 Q2	$3.55M	Buy	+150,000	New	+$3.01M	0.01%	672
2017 Q4	–	Sell	-161,000	Closed	-$2.25M	–	772
2017 Q3	$2.25M	Sell	161,000 -930,000	-85%	-$9.27M	0.01%	668
2017 Q2	$9.63M	Buy	1,091,000 +141,000	+15%	+$990K	0.02%	575
2017 Q1	$6.15M	Buy	+950,000	New	+$4.81M	0.02%	595

Adage Capital Partners's IMMU Position: Q4 2020 in Review

Adage Capital Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,200,000 shares — an estimated $102M sold.

Adage Capital Partners first reported a position in IMMU in Q1 2017 and held it in 6 quarters. The position peaked at $102M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Adage Capital Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Adage Capital Partners sold 1,200,000 Immunomedics Inc shares in Q4 2020, an estimated $102M.
Adage Capital Partners first reported a position in Immunomedics Inc in Q1 2017 and held it in 6 quarters.
Adage Capital Partners's Immunomedics Inc position peaked at $102M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.